NEW YORK, August 6, 2026, 12:08 p.m. EDT
- Rocket Lab stock rose 4.1% to $77.89 in Thursday’s regular session. The company was valued at approximately $47.2 billion.
- Space Force disclosed two awards with a combined value of $663 million, representing around 30% of Rocket Lab’s reported backlog as of March.
- Second-quarter earnings are scheduled for release after the close on Monday. The company’s initial forecast projects revenue between $225 million and $240 million.
Rocket Lab Corporation shares rose 4.1% to $77.89 late Thursday morning after investors considered the outcome of a successful Electron mission and the company’s recent defense contract.
Execution remains the primary concern for investors. The $397 million Space Force contract relies on Neutron, a vehicle yet to make its first launch. This contract comprises 59.9% of Rocket Lab’s two most recent major awards from the Space Force.
The combined value of these awards is cited at $663 million, representing 30.1% of the March backlog and 3.3 times revenue in the first quarter. This figure amounts to just 1.4% of Rocket Lab’s present equity value.
| Award date | Program | Announced value | Scope | Main execution dependency |
|---|---|---|---|---|
| Aug. 4 | SB-AMTI Flatellites | $397 million | Design, put in orbit and manage several spacecraft | Neutron and satellite integration |
| July 27 | Missile-defense launches | $266 million | 12 suborbital missions, potential for six additional | Launch frequency and Alaska site expansion |
| Combined | Two Space Force programs | $663 million | Satellites, mission and launch activities | 59.9% tied to the Neutron-related program |
The figures reported represent the values of the contracts as announced, rather than near-term revenue. The $397 million sum specifically covers an option to buy more Flatellites. The $266 million figure accounts for as many as six optional launches.
| Comparison base | Reported value | $663 million as a percentage | Investor reading |
|---|---|---|---|
| First-quarter revenue | $200.3 million | 331.0% | Exceeds three quarters of present revenue base |
| March backlog | $2.2 billion | 30.1% | Significant possible increase in contracted work |
| Current market value | $47.2 billion | 1.4% | Market value reflects expectations of much greater scale |
Rocket Lab’s reported Q1 numbers and Thursday’s market capitalization form the basis of calculations. The recognition of backlog and revenue could shift depending on contract options, timing, and accounting methods.
With the updated contract, Rocket Lab is set to construct, launch, and manage several Flatellites. These satellites will deliver tracking information to the Space Force.
Chief Executive Peter Beck stated that Rocket Lab’s “vertically integrated, constellation-class satellite capabilities” reinforced its standing. That assertion now faces a tougher challenge. Rocket Lab Corporation
Electron delivered new operating evidence on Thursday as Rocket Lab launched QPS-SAR-13 on its 92nd Electron flight, marking the company’s 13th mission this year. Rocket Lab reported that all eight iQPS deployments were completed successfully.
iQPS operates as a subsidiary of QPS Holdings (TYO:464A). Rocket Lab announced that ten additional Electron launches have been reserved through 2030.
The milestone reduces risk linked to Electron, but it does not confirm Neutron. For investors, the latest contract moves Neutron from being an optional benefit to a risk involving contract conversion.
| Metric | First-quarter actual | Second-quarter preliminary guidance | Midpoint movement |
|---|---|---|---|
| Revenue | $200.3 million | $225 million-$240 million | Rises 16.1% quarter-on-quarter |
| GAAP gross margin | 38.2% | 33%-35% | Drops 4.2 percentage points |
| Adjusted EBITDA loss | $11.8 million | $20 million-$26 million | Loss increases by $11.2 million |
| Backlog | $2.2 billion | No guidance | Focus remains on contract conversion |
Second-quarter numbers are based on company forecasts and are still provisional. The midpoint benchmarks come from $232.5 million in revenue, a gross margin of 34%, and an adjusted EBITDA loss of $23 million.
Rocket Lab will release second-quarter earnings after the market closes on Monday. Investors may find that sales growth does not resolve ongoing questions over its valuation.
The Motley Fool, in an analysis distributed by Yahoo, noted that updates on Neutron bookings or a confirmed hot-fire schedule would be the most significant information. Share price movement following first-quarter results indicated that investors are still highly responsive to news about launch milestones.
A contributor on Seeking Alpha expressed greater optimism, assigning a Strong Buy rating and a price target of $128.56. Dhierin Bechai projected a 33% EBITDA margin and anticipated positive free cash flow by 2029. These are early third-party projections rather than official company guidance.
| Firm and analyst | Action date | Latest stance | Target | Approximate move from $77.89 |
|---|---|---|---|---|
| Piper Sandler NYSE:PIPR, Alexander Potter | July 15 | Started at Neutral | $83 | +7% |
| Bank of America NYSE:BAC, Ronald Epstein | June 30 | Buy; target increased | $115 | +48% |
| Needham, Ryan Koontz | June 30 | Buy confirmed | $120 | +54% |
| Roth Capital, Suji Desilva | June 29 | Buy; target increased | $130 | +67% |
| KeyCorp NYSE:KEY, Michael Leshock | June 15 | Raised to Overweight | $135 | +73% |
| 22-analyst consensus | Aug. 6 snapshot | Moderate Buy | $110.29 | +42% |
The implied moves were updated based on Thursday’s share price of $77.89. Analyst data from MarketBeat is sourced from Benzinga along with additional providers.
Analysts generally have a positive outlook, though opinions vary. MarketBeat lists three Strong Buy ratings, 13 Buys, five Holds and one Sell. Price targets are spread between $60 and $150.
The stock’s valuation also makes it sensitive to interest rate movements. According to Trefis, Rocket Lab experienced an average decline of 37% during five major market shocks, compared with an average 13% drop for the S&P 500. During the 2022 rate shock, Rocket Lab shares fell 70% from peak to trough.
Risks: Neutron is yet to launch, and optional contracts might not be exercised. The values from the award will not convert into immediate revenue. Initial guidance indicates a reduced gross margin and a larger adjusted EBITDA loss. Rising rates could put pressure on the valuation before performance improves.
The next significant test is set for August 10. Establishing a clear Neutron schedule would link contract awards to anticipated revenue. Any further delay would widen that gap again.
